Zhejiang Shouxiangu Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 542.63 million compared to CNY 507.64 million a year ago. Revenue was CNY 542.63 million compared to CNY 507.64 million a year ago.

Net income was CNY 139.36 million compared to CNY 130.14 million a year ago. Basic earnings per share from continuing operations was CNY 0.71 compared to CNY 0.67 a year ago. Diluted earnings per share from continuing operations was CNY 0.71 compared to CNY 0.67 a year ago.